The CD105:CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects.

Ahmed Al-QaissiSaeed AlqarniZeeshan JavedStephen L AtkinThozhukat SathyapalanRebecca V VinceLeigh A Madden

Published in: Endocrine (2019)

These data suggest that women with PCOS have an altered endothelial MP release in favour of CD106. Thus a potential activated endothelial state exists in women with PCOS with a shift towards a predominantly CD106MP profile.

Keyphrases

polycystic ovary syndrome
insulin resistance
type diabetes
endothelial cells
electronic health record
cardiovascular disease
metabolic syndrome
machine learning
glycemic control
skeletal muscle
big data
climate change
artificial intelligence
deep learning
data analysis